US equities |
NVDA $178.67 ▼-4.27% AMD $508.58 ▲+13.26% MU $733.15 ▲+6.25% AAPL $350.69 ▲+2.43% SPCX $142.07 ▲+5.81% MSFT $545.18 ▲+2.75% AMZN $266.93 ▲+2.94% TSLA $378.05 ▲+5.54%
FinancialContent

Senseonics Holdings, Inc. - Common Stock (NQ:SENS)

9.800 +1.210 (+14.09%)
Delayed Quote Updated: 4:00 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Senseonics Holdings, Inc. - Common Stock

News headline image
Senseonics Holdings, Inc. Reports Third Quarter 2026 Financial Results
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Initiates First-in-Human Study of Freedom, Designed to be the World’s First CGM System with No On-body Component
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern Time
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics To Participate in Upcoming Institutional Investor Conferences
From Senseonics Holdings, Inc.
Via GlobeNewswire
News headline image
Senseonics Holdings, Inc. Reports Second Quarter 2026 Financial Results
From Senseonics Holdings, Inc.
Via GlobeNewswire